Growth and nutritional biomarkers in preterm infants in NICU â?? a Multicentric Study in India - PTF

estle India Limited0 个研究点目标入组 30 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Stable Preterm AGA infants born between 28 to 34 weeks of gestational age who are on enteral feeding,
•Singleton gestation

•On any other clinical study affecting nutritional management during the study period
•Decision to not start minimum enteral feed within 48 hours of birth
•Unable to obtain informed consent from parent (s) or legal guardian prior to the initiation of enteral feeding
•Infants experiencing early onset sepsis (i.e. symptoms requiring antibiotic therapy and confirmed by a positive blood culture occurring before the 3rd day of life).
•Presence of clinically significant congenital heart disease
•Presence of any major congenital malformations, chromosomal abnormality or major gastro intestinal disease known to affect growth
•Liver failure as detected by (if laboratory data is available) aspartate aminotransferase, alanine aminotransferase, gamma-glutamyl transferase, and direct bilirubin serum values 3-fold higher than reference range.
•Peri-/intra-ventricular haemorrhage (grade 3-4 in Papille classification) determined using cranial ultrasonography, if it is performed.
•Other serious disorders of cardiac/ respiratory/ endocrine/ hematological/ gastrointestinal/ other systems, or serious diseases requiring surgical intervention
•Reasonable potential for early transfer to a non-study institution

发起方

estle India Limited